These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 22028287)

  • 1. Measuring in vivo tumor pHe with CEST-FISP MRI.
    Sheth VR; Li Y; Chen LQ; Howison CM; Flask CA; Pagel MD
    Magn Reson Med; 2012 Mar; 67(3):760-8. PubMed ID: 22028287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved pH measurements with a single PARACEST MRI contrast agent.
    Sheth VR; Liu G; Li Y; Pagel MD
    Contrast Media Mol Imaging; 2012; 7(1):26-34. PubMed ID: 22344877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging in vivo extracellular pH with a single paramagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent.
    Liu G; Li Y; Sheth VR; Pagel MD
    Mol Imaging; 2012 Feb; 11(1):47-57. PubMed ID: 22418027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and characterization of a new irreversible responsive PARACEST MRI contrast agent that detects nitric oxide.
    Liu G; Li Y; Pagel MD
    Magn Reson Med; 2007 Dec; 58(6):1249-56. PubMed ID: 18046705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI.
    Chen LQ; Howison CM; Jeffery JJ; Robey IF; Kuo PH; Pagel MD
    Magn Reson Med; 2014 Nov; 72(5):1408-17. PubMed ID: 24281951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multislice CEST MRI improves the spatial assessment of tumor pH.
    Randtke EA; Granados JC; Howison CM; Pagel MD; Cárdenas-Rodríguez J
    Magn Reson Med; 2017 Jul; 78(1):97-106. PubMed ID: 27465207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using two chemical exchange saturation transfer magnetic resonance imaging contrast agents for molecular imaging studies.
    Ali MM; Liu G; Shah T; Flask CA; Pagel MD
    Acc Chem Res; 2009 Jul; 42(7):915-24. PubMed ID: 19514717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH imaging of mouse kidneys in vivo using a frequency-dependent paraCEST agent.
    Wu Y; Zhang S; Soesbe TC; Yu J; Vinogradov E; Lenkinski RE; Sherry AD
    Magn Reson Med; 2016 Jun; 75(6):2432-41. PubMed ID: 26173637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Frequency-Selective pH-Responsive paraCEST Agent.
    Ratnakar SJ; Chirayil S; Funk AM; Zhang S; Queiró JF; Geraldes CFGC; Kovacs Z; Sherry AD
    Angew Chem Int Ed Engl; 2020 Nov; 59(48):21671-21676. PubMed ID: 32726500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new contrast in MR mammography by means of chemical exchange saturation transfer (CEST) imaging at 3 Tesla: preliminary results.
    Schmitt B; Zamecnik P; Zaiss M; Rerich E; Schuster L; Bachert P; Schlemmer HP
    Rofo; 2011 Nov; 183(11):1030-6. PubMed ID: 22034086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SWIFT-CEST: a new MRI method to overcome T₂ shortening caused by PARACEST contrast agents.
    Soesbe TC; Togao O; Takahashi M; Sherry AD
    Magn Reson Med; 2012 Sep; 68(3):816-21. PubMed ID: 22213371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI.
    Ali MM; Yoo B; Pagel MD
    Mol Pharm; 2009; 6(5):1409-16. PubMed ID: 19298054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEST-MRI for glioma pH quantification in mouse model: Validation by immunohistochemistry.
    Ferrauto G; Di Gregorio E; Auboiroux V; Petit M; Berger F; Aime S; Lahrech H
    NMR Biomed; 2018 Nov; 31(11):e4005. PubMed ID: 30256478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ytterbium-based PARACEST agent: feasibility of CEST imaging on a clinical MR scanner.
    Takayama Y; Yoshiura T; Nishie A; Nakayama T; Hatakenaka M; Kato N; Yoshise S; Keupp J; Burdinski D; Honda H
    Magn Reson Med Sci; 2012; 11(1):35-41. PubMed ID: 22450385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-responsive paramagnetic CEST agents.
    Angelovski G; Chauvin T; Pohmann R; Logothetis NK; Tóth E
    Bioorg Med Chem; 2011 Feb; 19(3):1097-105. PubMed ID: 20691598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous experimental determination of labile proton fraction ratio and exchange rate with irradiation radio frequency power-dependent quantitative CEST MRI analysis.
    Sun PZ; Wang Y; Xiao G; Wu R
    Contrast Media Mol Imaging; 2013; 8(3):246-51. PubMed ID: 23606428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NiCEST approach: nickel(II) paraCEST MRI contrast agents.
    Olatunde AO; Dorazio SJ; Spernyak JA; Morrow JR
    J Am Chem Soc; 2012 Nov; 134(45):18503-5. PubMed ID: 23102112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic PARACEST contrast agents for magnetic resonance imaging.
    Pikkemaat JA; Wegh RT; Lamerichs R; van de Molengraaf RA; Langereis S; Burdinski D; Raymond AY; Janssen HM; de Waal BF; Willard NP; Meijer EW; Grüll H
    Contrast Media Mol Imaging; 2007; 2(5):229-39. PubMed ID: 17937448
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.